Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Upcoming Talks
DNA damage, cancer and aging and the unexpected impact of nutrition and gene length
Thursday, 21 May 2026, 12pm to 1pm
Webinar – Reviewing Lay Summaries as a Public Partner (Online Training)
Thursday, 21 May 2026, 1pm to 2.30pm
Latest publications
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18
Spatio-temporal eco-evolutionary dynamics of prey-predator systems with defended and undefended prey
Preprint
Roy S. et al, (2026)